Dubuque Bank & Trust CO Novartis Ag Transaction History

Dubuque Bank & Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 10, 2019	SELL	$75.4 - $92.8 $31,894 - $39,254	-423 Closed	0 $0
Q1 2019 Apr 02, 2019	SELL	$75.32 - $86.15 $81,872 - $93,645	-1,087 Reduced 71.99%	423 $41,000
Q3 2018 Oct 30, 2018	SELL	$66.94 - $77.43 $2,342 - $2,710	-35 Reduced 2.27%	1,510 $130,000
Q2 2018 Jul 17, 2018	SELL	$64.91 - $73.36 $1,298 - $1,467	-20 Reduced 1.28%	1,545 $117,000
Q1 2018 May 10, 2018	SELL	$70.39 - $84.15 $7,039 - $8,415	-100 Reduced 6.01%	1,565 $126,000
Q4 2017 Feb 06, 2018	SELL	$72.33 - $77.64 $60,033 - $64,441	-830 Reduced 33.27%	1,665 $139,000
Q3 2017 Oct 13, 2017	BUY	$74.14 - $77.27 $184,979 - $192,788	2,495	2,495 $214,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Dubuque Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Dubuque Bank & Trust CO with notifications on news.